RxDoctor Payments Data

Lawrence Lavery

Foot Surgery · San Antonio, TXNPI 1992765655

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $36,167 of the $59,442 with a category attached, or 60.8%. It is spread thinly across 26 manufacturers, the largest accounting for just 17.9%. Among foot surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$59,442in general payments, 2019–2025

Across 78 payments — averaging $762.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paratek Pharmaceuticals, Inc.$11K
  • Inari Medical, Inc.$9K
  • KCI USA, Inc.$8K
  • Sanara Medtech Inc.$7K
  • Integra Lifesciences Corporation$6K
  • Polarityte, Inc.$5K
  • plus $14K from 20 others
$1,094,564in research payments, 2019–2025

Across 246 payments — averaging $4449.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biotissue Holdings Inc.$550K
  • Smith+Nephew$300K
  • AstraZeneca$129K
  • Integra Lifesciences Corporation$52K
  • Osiris Therapeutics Inc.$41K
  • Acera Surgical, Inc.$19K
  • plus $3K from 1 others

What the payments were for

  • Consulting fees$36,16761%
  • Speaking & faculty fees$12,05020%
  • Travel & lodging$6,87612%
  • Food & beverage$4,3507%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$59,442 in reported general payments places this provider in the 95th percentile of 71 foot surgery providers in Texas.

See all foot surgery providers in Texas

Medicare billing

Part B allowed, 2024
$60,829
Medicare patients
130
Services billed
535

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav36$556
Gabapentin11$489
Doxycycline Monohydrate14$180

Paid to pharmacies, not to this prescriber.

Other foot surgery in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →